Chigasaki, Japan

Shohei Shiraishi

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2021-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shohei Shiraishi. Retrieved from https://idiyas.com/inventor/shohei-shiraishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Shohei Shiraishi in the Field of Imidazo[1,2-b]pyridazine Derivatives

Introduction

Shohei Shiraishi, an accomplished inventor based in Chigasaki, Japan, has made significant contributions to the field of medicinal chemistry through his innovative work on imidazo[1,2-b]pyridazine derivatives. With a total of two patents to his name, Shiraishi is recognized for developing industrially useful methods that enhance chemical production processes.

Latest Patents

Shiraishi's latest patents focus on a novel method for producing 3,6-disubstituted imidazo[1,2-b]pyridazine derivatives. This method utilizes 6-fluoroimidazo[1,2-b]pyridazine as a starting material and involves an aromatic substitution reaction that capitalizes on C—H activation through palladium. The innovation ensures a more efficient synthesis of these important chemical compounds, which have various applications in pharmaceuticals.

Career Highlights

Shohei Shiraishi works for Daiichi Sankyo Company, Limited, where he continues to push the boundaries of research and development in the pharmaceutical industry. His contributions have not only advanced the understanding of imidazo[1,2-b]pyridazine chemistry but also paved the way for new therapeutic agents.

Collaborations

Shiraishi collaborates with notable colleagues, including Ryoji Koike and Yoshifumi Hachisu, further enhancing the potential for innovative breakthroughs in their shared field of expertise. Their collective efforts in research demonstrate the importance of teamwork in driving scientific advancements.

Conclusion

Overall, Shohei Shiraishi’s work in developing methods for producing 3,6-disubstituted imidazo[1,2-b]pyridazine derivatives reflects his commitment to innovation and excellence in chemistry. His patents not only signify personal achievement but also contribute to the broader goals of improving pharmaceutical development and expanding research capabilities within the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…